DENND5B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.924600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.674400E-01
Normal-vs-Stage2
5.782400E-01
Normal-vs-Stage3
5.027400E-01
Normal-vs-Stage4
9.711400E-01
Stage1-vs-Stage2
9.192600E-01
Stage1-vs-Stage3
5.516200E-01
Stage1-vs-Stage4
2.417900E-02
Stage2-vs-Stage3
5.989000E-01
Stage2-vs-Stage4
5.150400E-02
Stage3-vs-Stage4
2.801800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.878200E-01
Normal-vs-AfricanAmerican
6.864200E-01
Normal-vs-Asian
5.341200E-01
Caucasian-vs-AfricanAmerican
2.527200E-01
Caucasian-vs-Asian
5.728200E-01
AfricanAmerican-vs-Asian
2.073000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.134200E-01
Normal-vs-Female
5.679800E-01
Male-vs-Female
4.034800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.101400E-01
Normal-vs-Age(41-60Yrs)
6.674600E-01
Normal-vs-Age(61-80Yrs)
5.752000E-01
Normal-vs-Age(81-100Yrs)
4.352000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.691200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.824800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.058210E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.484590E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.5126199999993E-05
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.296170E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.192600E-01
Normal-vs-Daily Drinker
2.565200E-01
Normal-vs-Weekly Drinker
5.028200E-01
Normal-vs-Occasional Drinker
4.679200E-01
Normal-vs-Social Drinker
5.365800E-01
Non Drinker-vs-Daily Drinker
6.711800E-01
Non Drinker-vs-Weekly Drinker
8.258600E-01
Non Drinker-vs-Occasional Drinker
2.657000E-01
Non Drinker-vs-Social Drinker
8.594800E-01
Daily Drinker-vs-Weekly Drinker
5.760800E-01
Daily Drinker-vs-Occasional Drinker
5.029600E-01
Daily Drinker-vs-Social Drinker
8.209000E-01
Weekly Drinker-vs-Occasional Drinker
2.326000E-01
Weekly Drinker-vs-Social Drinker
7.316600E-01
Occasional Drinker-vs-Social Drinker
3.815400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.836000E-01
Normal-vs-Grade 2
1.373420E-01
Normal-vs-Grade 3
1.863230E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.231600E-01
Grade 1-vs-Grade 3
9.510600E-01
Grade 1-vs-Grade 4
2.836000E-01
Grade 2-vs-Grade 3
5.104600E-01
Grade 2-vs-Grade 4
1.373420E-01
Grade 3-vs-Grade 4
1.863230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.274200E-01
Normal-vs-NonDiabetic
5.807200E-01
Diabetic-vs-NonDiabetic
3.174600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.664400E-01
Normal-vs-NoPancreatitis
5.718600E-01
Pancreatitis-vs-NoPancreatitis
9.322600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.100600E-01
Normal-vs-N1
5.890200E-01
N0-vs-N1
7.846600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.041000E-01
Normal-vs-TP53-NonMutant
6.349600E-01
TP53-Mutant-vs-TP53-NonMutant
7.088200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
